APOH and autoimmune polyendocrinopathy: This suggests that anti-β2GPI-D1 may provide greater diagnostic value in distinguishing APS from other autoimmune diseases and healthy individuals, while its diagnostic utility in differentiating APS from aPL carriers may be limited.